The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Residual Arachidonic Acid–Induced Platelet Activation via an Adenosine Diphosphate–Dependent but Cyclooxygenase-1– and Cyclooxygenase-2–Independent Pathway: A 700-Patient Study of Aspirin Resistance
Open accessAbstract
Background— Thrombotic events still occur in aspirin-treated patients with coronary artery disease. Methods and Results— To better understand aspirin “resistance,” serum thromboxane B 2 (TXB 2 ) and flow cytometric measures of arachidonic acid–induced platelet activation (before and after the ex vivo addition of aspirin and indomethacin) were analyzed in 700 consecutive aspirin-treated patients undergoing cardiac catheterization. In 680 of 682 evaluable patients, serum TXB 2 concentrations were reduced compared with nonaspirinated healthy donors. Twelve patients had serum TXB 2 that was lower than nonaspirinated healthy donors but >10 ng/mL. Arachidonic acid stimulated greater platelet activation in patients with high serum TXB 2 (>10 ng/mL) than in patients with low serum TXB 2 . Addition of ex vivo aspirin reduced arachidonic acid–induced platelet activation to similar levels regardless of serum TXB 2 concentrations, which suggests that patients with high residual serum TXB 2 concentrations were either noncompliant or underdosed with aspirin. Among the remaining 98% of patients, ex vivo administration of either aspirin or indomethacin failed to prevent platelet activation across all degrees of arachidonic acid–induced platelet activation and aspirin doses. Although the patients were not randomized with respect to clopidogrel treatment, multivariate analysis showed that arachidonic acid–induced platelet activation was less in patients receiving clopidogrel. Conclusions— There is a residual arachidonic acid–induced platelet activation in aspirin-treated patients that (1) is caused by underdosing and/or noncompliance in only &2% of patients and (2) in the remaining patients, occurs via a cyclooxygenase-1 and cyclooxygenase-2 independent pathway, in direct proportion to the degree of baseline platelet activation, and is mediated in part by adenosine diphosphate–induced platelet activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patrono, C., Coller, B., Dalen, J. E., Fitz Gerald, G. A., Fuster, V., Gent, M., Hirsh, J., & Roth, G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.39s · Cited by 963
Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation.
Shattil, S. J., Hoxie, J. A., Cunningham, M., & Brass, L. F. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39154-8 · Cited by 942
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
Patrono, C., Coller, B., FitzGerald, G. A., Hirsh, J., & Roth, G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.234s · Cited by 671
Furman, M. I., Benoit, S. E., Barnard, M. R., Valeri, C. R., Borbone, M. L., Becker, R. C., Hechtman, H. B., & Michelson, A. D. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00510-x · Cited by 537
Self-citationAspirin and Clopidogrel: Efficacy, Safety, and the Issue of Drug Resistance
Cattaneo, M. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000145980.39477.a9 · Cited by 411
Wiviott, S. D., Antman, E. M., Winters, K. J., Weerakkody, G., Murphy, S. A., Behounek, B. D., Carney, R. J., Lazzam, C., McKay, R. G., McCabe, C. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.502815 · Cited by 381
Aspirin resistance: position paper of the Working Group on Aspirin Resistance
MICHELSON, A. D., CATTANEO, M., EIKELBOOM, J. W., GURBEL, P., KOTTKE‐MARCHANT, K., KUNICKI, T. J., PULCINELLI, F. M., CERLETTI, C., & RAO, A. K. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01351.x · Cited by 325
Self-citationTantry, U. S., Bliden, K. P., & Gurbel, P. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.090 · Cited by 324
Platelet Function Testing in Cardiovascular Diseases
Michelson, A. D. (2004) · Circulation · doi:10.1161/01.cir.0000147228.29325.f9 · Cited by 317
Self-citationMolecular Mechanism of Thromboxane A2-induced Platelet Aggregation
Paul, B. Z. S., Jin, J., & Kunapuli, S. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29108 · Cited by 276
Cited by
Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysis
Krasopoulos, G., Brister, S. J., Beattie, W. S., & Buchanan, M. R. (2008) · BMJ · doi:10.1136/bmj.39430.529549.be · Cited by 708
Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome
Ferreiro, J. L., & Angiolillo, D. J. (2011) · Circulation · doi:10.1161/circulationaha.109.913376 · Cited by 333
Methods for the Measurement of Platelet Function
Michelson, A. D. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.11.019 · Cited by 274
Self-citationThe Role of Aspirin in Cardiovascular Prevention
Gasparyan, A. Y., Watson, T., & Lip, G. Y. H. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.11.080 · Cited by 263
Platelet Activation and Inhibition iN Sickle cell disease (PAINS) study
Frelinger, A. L., Jakubowski, J. A., Brooks, J. K., Carmichael, S. L., Berny-Lang, M. A., Barnard, M. R., Heeney, M. M., & Michelson, A. D. (2014) · Platelets · doi:10.3109/09537104.2013.770136 · Cited by 60
Self-citation
Metadata
- Authors
- Frelinger, A. L., Furman, M. I., Linden, M. D., Li, Y., Fox, M. L., Barnard, M. R., & Michelson, A. D.
- Venue
- Circulation
- Published
- 2006-06-27
- Volume
- 113
- Issue
- 25
- Pages
- 2888-2896
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1990031788
- Cited by
- 307
- References
- 16
- FWCI
- 19.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Residual Arachidonic Acid–Induced Platelet Activation via an Adenosine Diphosphate–Dependent but Cyclooxygenase-1– and Cyclooxygenase-2–Independent Pathway: A 700-Patient Study of Aspirin Resistance. https://app.cochat.ai/papers/10.1161/circulationaha.105.596627
- The paper
- Frelinger, A. L., Furman, M. I., Linden, M. D., Li, Y., Fox, M. L., Barnard, M. R., & Michelson, A. D. (2006). Residual Arachidonic Acid–Induced Platelet Activation via an Adenosine Diphosphate–Dependent but Cyclooxygenase-1– and Cyclooxygenase-2–Independent Pathway: A 700-Patient Study of Aspirin Resistance. Circulation. https://doi.org/10.1161/circulationaha.105.596627
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.